Bibliography
- Donn SM, Sinha SK. Manual of Neonatal Respiratory Care. Mosby-Elsevier, Philadelphia; 2006
- Donn SM, Sinha SK. Minimising ventilator-induced lung injury in preterm infants. Arch Dis Child Fetal Neonatal Ed 2006;91:F226-30
- Sinha S, Moya F, Donn SM. Surfactant for respiratory distress syndrome: are there important clinical differences between preparations? Curr Opin Pediatr 2007;19:150-4
- Donn SM. Lucinactant: a novel synthetic surfactant for the treatment of respiratory distress syndrome. Expert Opin Investig Drugs 2005;14:329-34
- Moya F, Gadzinowski J, Bancalari E, et al. Superiority of a novel surfactant, Surfaxin (lucinactant) over Exosurf in preventing respiratory distress syndrome in very preterm infants: a pivotal, multinational, randomized trial. Pediatrics 2005;115:1018-29
- Sinha SK, Lacaze-Masmonteil T, Valls-I-Soler A, et al. Randomized controlled trial of a new generation surfactant, Surfaxin (lucinactant) versus poractant alfa (Curosurf) for the prevention and treatment of respiratory distress syndrome in very preterm infants. Pediatrics 2005;115:1030-8
- Cochrane CG, Revak SD. Protein-phospholipid interactions in pulmonary surfactant. The Parker B. Francis Lectureship. Chest 1994;105(Suppl):57S-62S
- Cochrane CG, Revak SD. Pulmonary surfactant protein B (SP-B): structure-function relationships. Science 1991;254:566-8
- Nutt M, Patel N, Rairkar M, et al. Comparison of the novel lung surfactant Surfaxin (lucinactant) with currently available commercial products. Pediatr Res 2004;55:514A
- Johnson ME, Rodriguez L, Pearson R, Rairkar M. KL4-surfactant (Aerosurf) retains surface activity after aerosolization. E-PAS 2007;61:6292.7
- Finer NN, Merritt TA, Bernstein G, et al. A multicenter pilot study of Aerosurf™ delivered via nasal continuous positive airway pressure (nCPAP) to prevent respiratory distress syndrome in preterm neonates. Pediatr Res 2006;59:PAS2006:4840.138
- Mazela J, Merritt TA, Finer NN. Aerosolized surfactants. Curr Opin Pediatr 2007;19:155-62
- Jacobs H, Jobe A, Ikegami M, Jones S. Surfactant phosphatidylcholine source, fluxes, and turnover times in 3-day-old, 10-day-old, and adult rabbits. J Biol Chem 1982;257:1805-10
- Glatz T, Ikegami M, Jobe A. Metabolism of exogenously administered natural surfactant in the newborn lamb. Pediatr Res 1982;16:711-5
- Stocks J, Hislop A. Structure and function of the respiratory system. Developmental aspects and their relevance to aerosol delivery. In: Bisgaard H, O'Callaghan C, Smaldone G, editors. Drug Delivery to the Lung. New York: Marcel Dekker; 2002, p. 47-104
- Dolovich M. Influence of inspiratory flow rate, particle size, and airway caliber on aerosolized drug delivery to the lung. Respir Care 2000;45:597-608
- Cole C. Special problems in aerosol delivery: neonatal and pediatric considerations. Respir Care 2000;45:646-51